Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Biotech
Amgen obesity drug matches competition but investors unimpressed
Amgen claims to have made weight loss history by producing the first proof of body weight reduction for a monthly treatment in a phase 2 study.
James Waldron
Nov 26, 2024 10:11am
Versant unveils Pep2Tango, a biotech with next-gen obesity hopes
Nov 21, 2024 11:11am
Pfizer, Flagship return to obesity as part of 10-program collab
Nov 20, 2024 8:05am
Gubra reveals early data for once-weekly obesity asset
Nov 13, 2024 5:56pm
Metsera follows phase 1 weight loss data with $215M series B
Nov 13, 2024 9:15am
AstraZeneca still 'playing to win' in obesity, execs say
Nov 4, 2024 11:49am
